SEC Filings - Ultragenyx Pharmaceutical Inc.

SEC Filings

Filing date	Description	Form	View
Mar 08, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-016931.pdf 0001209191-22-016931.xls
Mar 08, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-016930.pdf 0001209191-22-016930.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015799.pdf 0001209191-22-015799.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015802.pdf 0001209191-22-015802.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015806.pdf 0001209191-22-015806.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015811.pdf 0001209191-22-015811.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015819.pdf 0001209191-22-015819.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015815.pdf 0001209191-22-015815.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015823.pdf 0001209191-22-015823.xls
Mar 03, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-22-015830.pdf 0001209191-22-015830.xls

INVESTORS & MEDIA

SHAREHOLDER TOOLS